235 related articles for article (PubMed ID: 11560493)
21. Dissecting the structure, thermodynamic stability, and aggregation properties of the A25T transthyretin (A25T-TTR) variant involved in leptomeningeal amyloidosis: identifying protein partners that co-aggregate during A25T-TTR fibrillogenesis in cerebrospinal fluid.
Azevedo EP; Pereira HM; Garratt RC; Kelly JW; Foguel D; Palhano FL
Biochemistry; 2011 Dec; 50(51):11070-83. PubMed ID: 22091638
[TBL] [Abstract][Full Text] [Related]
22. Kinetic stabilization of an oligomeric protein under physiological conditions demonstrated by a lack of subunit exchange: implications for transthyretin amyloidosis.
Wiseman RL; Green NS; Kelly JW
Biochemistry; 2005 Jun; 44(25):9265-74. PubMed ID: 15966751
[TBL] [Abstract][Full Text] [Related]
23. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.
Green NS; Foss TR; Kelly JW
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14545-50. PubMed ID: 16195386
[TBL] [Abstract][Full Text] [Related]
24. Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution.
Sebastião MP; Lamzin V; Saraiva MJ; Damas AM
J Mol Biol; 2001 Mar; 306(4):733-44. PubMed ID: 11243784
[TBL] [Abstract][Full Text] [Related]
25. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer.
Palaninathan SK; Mohamedmohaideen NN; Snee WC; Kelly JW; Sacchettini JC
J Mol Biol; 2008 Oct; 382(5):1157-67. PubMed ID: 18662699
[TBL] [Abstract][Full Text] [Related]
26. Cooperative stabilization of transthyretin by clusterin and diflunisal.
Greene MJ; Klimtchuk ES; Seldin DC; Berk JL; Connors LH
Biochemistry; 2015 Jan; 54(2):268-78. PubMed ID: 25478940
[TBL] [Abstract][Full Text] [Related]
27. The effect of iodide and chloride on transthyretin structure and stability.
Hörnberg A; Hultdin UW; Olofsson A; Sauer-Eriksson AE
Biochemistry; 2005 Jul; 44(26):9290-9. PubMed ID: 15981995
[TBL] [Abstract][Full Text] [Related]
28. Fluorotryptophan Incorporation Modulates the Structure and Stability of Transthyretin in a Site-Specific Manner.
Sun X; Dyson HJ; Wright PE
Biochemistry; 2017 Oct; 56(41):5570-5581. PubMed ID: 28920433
[TBL] [Abstract][Full Text] [Related]
29. Transthyretin Anti-Amyloidogenic and Fibril Disrupting Activities of
Eze FN; Ingkaninan K; Prapunpoj P
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31835306
[TBL] [Abstract][Full Text] [Related]
30. Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity.
Hammarström P; Jiang X; Hurshman AR; Powers ET; Kelly JW
Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16427-32. PubMed ID: 12351683
[TBL] [Abstract][Full Text] [Related]
31. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?
Hammarström P; Sekijima Y; White JT; Wiseman RL; Lim A; Costello CE; Altland K; Garzuly F; Budka H; Kelly JW
Biochemistry; 2003 Jun; 42(22):6656-63. PubMed ID: 12779320
[TBL] [Abstract][Full Text] [Related]
32. Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses.
Johnson SM; Wiseman RL; Sekijima Y; Green NS; Adamski-Werner SL; Kelly JW
Acc Chem Res; 2005 Dec; 38(12):911-21. PubMed ID: 16359163
[TBL] [Abstract][Full Text] [Related]
33. Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid disease.
Wiseman RL; Powers ET; Kelly JW
Biochemistry; 2005 Dec; 44(50):16612-23. PubMed ID: 16342952
[TBL] [Abstract][Full Text] [Related]
34. Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.
Almeida MR; Macedo B; Cardoso I; Alves I; Valencia G; Arsequell G; Planas A; Saraiva MJ
Biochem J; 2004 Jul; 381(Pt 2):351-6. PubMed ID: 15080795
[TBL] [Abstract][Full Text] [Related]
35. Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions.
Zhang Q; Kelly JW
Biochemistry; 2003 Jul; 42(29):8756-61. PubMed ID: 12873136
[TBL] [Abstract][Full Text] [Related]
36. The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis.
Jiang X; Buxbaum JN; Kelly JW
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14943-8. PubMed ID: 11752443
[TBL] [Abstract][Full Text] [Related]
37. Thermodynamic Stability and Aggregation Kinetics of EF Helix and EF Loop Variants of Transthyretin.
Ferguson JA; Sun X; Dyson HJ; Wright PE
Biochemistry; 2021 Mar; 60(10):756-764. PubMed ID: 33645214
[TBL] [Abstract][Full Text] [Related]
38. Quantification of quaternary structure stability in aggregation-prone proteins under physiological conditions: the transthyretin case.
Robinson LZ; Reixach N
Biochemistry; 2014 Oct; 53(41):6496-510. PubMed ID: 25245430
[TBL] [Abstract][Full Text] [Related]
39. Trapping the monomer of a non-amyloidogenic variant of transthyretin: exploring its possible use as a therapeutic strategy against transthyretin amyloidogenic diseases.
Palhano FL; Leme LP; Busnardo RG; Foguel D
J Biol Chem; 2009 Jan; 284(3):1443-53. PubMed ID: 18984591
[TBL] [Abstract][Full Text] [Related]
40. Kinetic stabilization of an oligomeric protein by a single ligand binding event.
Wiseman RL; Johnson SM; Kelker MS; Foss T; Wilson IA; Kelly JW
J Am Chem Soc; 2005 Apr; 127(15):5540-51. PubMed ID: 15826192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
